Out-of-pocket costs for patients diagnosed with high-grade glioma and their carers
A HGG diagnosis has a significant and sustained financial impact on people who are diagnosed and their carers. Patients experience significant additional costs relating to their diagnosis and travel to receive care, and their carers also continue to experience sustained costs whilst managing the additional tasks associated with informal caregiving.
Authors
- Anna K. Nowak (ORCID: https://orcid.org/0000-0002-9317-9526)
- Cameron Wright (ORCID: https://orcid.org/0000-0002-1145-947X)
- Jade C. Newton (ORCID: https://orcid.org/0000-0001-8688-2048)
- Rachael Elizabeth Moorin (ORCID: https://orcid.org/0000-0001-8742-7151)
- Georgia Halkett (ORCID: https://orcid.org/0000-0003-4065-4044)
- Moira O’Connor (ORCID: https://orcid.org/0000-0002-7298-5553)
Institutions
- University of Tasmania (AU)
- Bentley University (US)
- The University of Western Australia (AU)
- Curtin University (AU)
- Fiona Stanley Hospital (AU)
- Sir Charles Gairdner Hospital (AU)
- Fremantle Hospital (AU)
- Fiona Stanley Fremantle Hospitals Group
Publication Details
- Journal
- Neuro-Oncology Practice
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1093/nop/npae107
- Citations
- 1
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Australian Government
- Cancer Australia
- Curtin University of Technology